The COVID-19 Emergency Response Act received
royal assent in Canada on March 25, 2020. It contains amendments to
both the Patent Act and the Food and Drugs Act.
These amendments are now the law.
Patent Act Amendments
The Patent Act amendments add to the section on the use
of patents by government, providing a new compulsory licensing
regime. Under new s. 19.4, the Commissioner of Patents shall
authorize the Government of Canada as well as any person specified
in the application to make, construct, use and sell a patented
invention to the necessary extent in order to respond to the public
health emergency described in the application. This language tracks
s. 43 of the Patent Act with respect to the rights granted
to a patentee. Such actions are specifically deemed not to be an
infringement of the patent.